IZELTABART
UNII 6XJ4U33P1G

Substance Identification & Data

This profile provides standardized clinical and technical data for Izeltabart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6XJ4U33P1G.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2642078-60-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
6XJ4U33P1G
CAS Registry Number
2642078-60-0
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
IZELTABART
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C190338
National Cancer Institute reference terminology for clinical and research data.
INN ID
12302
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Izeltabart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

IZELTABART

Common Names & Synonyms

GAMMA1 HEAVY CHAIN HUMANIZED (1-452) (VH HUMANIZED (HOMO SAPIENS IGHV3-64*07 (81.6%) -(IGHD) -IGHJ4*01 (80%), CDR-IMGT (8.8.16)(26-33.51-58.97-112))(1-123) - HOMO SAPIENS IGHG1*03, G1M3, NG1M1, G1V21 CH2 Y15.1, T16, E18, G1V44 CH3 C122 (CH1 R120 (220) (124-221), HINGE 1-15 (222-236), CH2 M>Y15.1 (258), S>T16 (260), T>E18 (262)(237-346), CH3 E12 (362), M14 (364), S>C122 (448) (347-451), CHS K2>DEL (452)) (124-452)), (226-218')- DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-218') (V-KAPPA (HOMO SAPIENS IGKV4-1*01 (77.2%) -IGKJ2*02 (100%), CDRIMGT (10.3.9)(27-36.54-56.93-101)) (1'-111') -HOMO SAPIENS IGKC*01 (100%), KM3, A45.1 (157), V101 (195)(112'-218')); DIMER (232-232'':235-235'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-S, GLYCOFORM ALFA
IMMUNOGLOBULIN G1 (258-TYROSINE,260-THREONINE,262-GLUTAMIC ACID,448-CYSTEINE,DE-C-TERMINAL-LYSINE), ANTI-(HUMAN METALLOPROTEINASE ADAM9) (HUMAN-MUS MUSCULUS MONOCLONAL MGA021 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MGA021 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS ADAM9 (ADAM METALLOPEPTIDASE DOMAIN 9, CONE ROD DYSTROPHY 9, CORD9, MELTRIN GAMMA, MDC9, MCMP)), HUMANIZED MONOCLONAL ANTIBODY
IZELTABART [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus